Chapter 16 Endocannabinoid System and Fear Conditioning

Vitamins and Hormones

Volumn 81, Issue C, 2009, Pages 421-440

  Resstel, Leonardo B M ^a   Moreira, Fabrício A ^b   Guimarães, Francisco S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; RIMONABANT;

ANIMAL; BRAIN; CONDITIONING; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; FEAR; PHYSIOLOGY; REVIEW;

ANIMALS; BRAIN; CONDITIONING (PSYCHOLOGY); ENDOCANNABINOIDS; FEAR; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1;

EID: 67651148005     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(09)81016-9     Document Type: Review

References (129)

1. Ameri A. The effects of cannabinoids on the brain. Prog. Neurobiol. 58 (1999) 315-348
2. Anagnostaras S.G., Maren S., and Fanselow M.S. Temporally graded retrograde amnesia of contextual fear after hippocampal damage in rats: Within-subjects examination. J. Neurosci. 19 (1999) 1106-1114
3. Arenos J.D., Musty R.E., and Bucci D.J. Blockade of cannabinoid CB1 receptors alters contextual learning and memory. Eur. J. Pharmacol. 539 (2006) 177-183
4. Baeg E.H., Kim Y.B., Jang J., Kim H.T., Mook-Jung I., and Jung M.W. Fast spiking and regular spiking neural correlates of fear conditioning in the medial prefrontal cortex of the rat. Cereb. Cortex 11 (2001) 441-451
5. Barrientos R.M., O'Reilly R.C., and Rudy J.W. Memory for context is impaired by injecting anisomycin into dorsal hippocampus following context exploration. Behav. Brain Res. 134 (2002) 299-306
6. Beck C.H., and Fibiger H.C. Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: With and without diazepam pretreatment. J. Neurosci. 15 (1995) 709-720
7. Beinfeld M.C., and Connolly K. Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids. Neurosci. Lett. 301 (2001) 69-71
8. Bishop S.J. Neurocognitive mechanisms of anxiety: An integrative account. Trends Cogn. Sci. 11 (2007) 307-316
9. Blanchard D.C., and Blanchard R.J. Innate and conditioned reactions to threat in rats with amygdaloid lesions. J. Comp. Physiol. Psychol. 81 (1972) 281-290
10. Bortolato M., Campolongo P., Mangieri R.A., Scattoni M.L., Frau R., Trezza V., La Rana G., Russo R., Calignano A., Gessa G.L., Cuomo V., and Piomelli D. Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharmacology 31 (2006) 2652-2659
11. Bouton M.E. Context and behavioral processes in extinction. Learn. Mem. 11 (2004) 485-494
12. Brown A.J. Novel cannabinoid receptors. Br. J. Pharmacol. 152 (2007) 567-575
13. Cahill L., and McGaugh J.L. Mechanisms of emotional arousal and lasting declarative memory. Trends Neurosci. 21 (1998) 294-299
14. Cannistraro P.A., and Rauch S.L. Neural circuitry of anxiety: Evidence from structural and functional neuroimaging studies. Psychopharmacol. Bull. 37 (2003) 8-25
15. Carrive P., Leung P., Harris J., and Paxinos G. Conditioned fear to context is associated with increased Fos expression in the caudal ventrolateral region of the midbrain periaqueductal gray. Neuroscience 78 (1997) 165-177
16. Carrive P., Lee J., and Su A. Lidocaine blockade of amygdala output in fear-conditioned rats reduces Fos expression in the ventrolateral periaqueductal gray. Neuroscience 95 (2000) 1071-1080
17. Chhatwal J.P., Davis M., Maguschak K.A., and Ressler K.J. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology 30 (2005) 516-524
18. Conde F., Maire-Lepoivre E., Audinat E., and Crepel F. Afferent connections of the medial frontal cortex of the rat. II. Cortical and subcortical afferents. J. Comp. Neurol. 352 (1995) 567-593
19. Davies S.N., Pertwee R.G., and Riedel G. Functions of cannabinoid receptors in the hippocampus. Neuropharmacology 42 (2002) 993-1007
20. Davis M. The role of the amygdala in fear and anxiety. Annu. Rev. Neurosci. 15 (1992) 353-375
21. Davis M. The role of amygdala in conditioned and unconditioned fear and anxiety. In: Aggleton J.P. (Ed). The Amygdala. 2nd edn. (2000), Oxford University Press, Oxford 213-287
22. de Oliveira Alvares L., Pasqualini Genro B., Diehl F., Molina V.A., and Quillfeldt J.A. Opposite action of hippocampal CB1 receptors in memory reconsolidation and extinction. Neuroscience 154 (2008) 1648-1655
23. Devane W.A., Dysarz III F.A., Johnson M.R., Melvin L.S., and Howlett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34 (1988) 605-613
24. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 (1992) 1946-1949
25. Dielenberg R.A., Carrive P., and McGregor I.S. The cardiovascular and behavioral response to cat odor in rats: Unconditioned and conditioned effects. Brain Res. 897 (2001) 228-237
26. Egashira N., Mishima K., Iwasaki K., and Fujiwara M. Intracerebral microinjections of delta 9-tetrahydrocannabinol: Search for the impairment of spatial memory in the eight-arm radial maze in rats. Brain Res. 952 (2002) 239-245
27. Egertova M., Giang D.K., Cravatt B.F., and Elphick M.R. A new perspective on cannabinoid signalling: Complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc. Biol. Sci. 265 (1998) 2081-2085
28. Egertova M., Cravatt B.F., and Elphick M.R. Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: Evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience 119 (2003) 481-496
29. Everitt B., Cardinal R., Hall J., Parkinson J., and Robbins T. Differential involvement of amygdala subsystems in appetitive conditioning and drug addiction. In: Aggleton J.P. (Ed). The Amygdala: A Functional Analysis. 2nd edn. (2000), Oxford University Press, Oxford 353-390
30. Fanselow M.S. Conditioned and unconditional components of post-shock freezing. Pavlov J. Biol. Sci. 15 (1980) 177-182
31. Fanselow M.S., and Helmstetter F.J. Conditional analgesia, defensive freezing, and benzodiazepines. Behav. Neurosci. 102 (1988) 233-243
32. Fanselow M.S., and Kim J.J. Acquisition of contextual Pavlovian fear conditioning is blocked by application of an NMDA receptor antagonist d,l-2-amino-5-phosphonovaleric acid to the basolateral amygdala. Behav. Neurosci. 108 (1994) 210-212
33. Fendt M., and Fanselow M.S. The neuroanatomical and neurochemical basis of conditioned fear. Neurosci. Biobehav. Rev. 23 (1999) 743-760
34. Finn D.P., Beckett S.R., Richardson D., Kendall D.A., Marsden C.A., and Chapman V. Evidence for differential modulation of conditioned aversion and fear-conditioned analgesia by CB1 receptors. Eur. J. Neurosci. 20 (2004) 848-852
35. Frankland P.W., and Bontempi B. The organization of recent and remote memories. Nat. Rev. Neurosci. 6 (2005) 119-130
36. Freund T.F., Katona I., and Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83 (2003) 1017-1066
37. Galeno T.M., Van Hoesen G.W., and Brody M.J. Central amygdaloid nucleus lesion attenuates exaggerated hemodynamic responses to noise stress in the spontaneously hypertensive rat. Brain Res. 291 (1984) 249-259
38. Garcia R., Vouimba R.M., Baudry M., and Thompson R.F. The amygdala modulates prefrontal cortex activity relative to conditioned fear. Nature 402 (1999) 294-296
39. Gentile C.G., Jarrell T.W., Teich A., McCabe P.M., and Schneiderman N. The role of amygdaloid central nucleus in the retention of differential pavlovian conditioning of bradycardia in rabbits. Behav. Brain Res. 20 (1986) 263-273
40. Giuffrida A., Beltramo M., and Piomelli D. Mechanisms of endocannabinoid inactivation: Biochemistry and pharmacology. J. Pharmacol. Exp. Ther. 298 (2001) 7-14
41. Gobbi G., Bambico F.R., Mangieri R., Bortolato M., Campolongo P., Solinas M., Cassano T., Morgese M.G., Debonnel G., Duranti A., Tontini A., Tarzia G., et al. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc. Natl. Acad. Sci. USA 102 (2005) 18620-18625
42. Grace A.A., and Rosenkranz J.A. Regulation of conditioned responses of basolateral amygdala neurons. Physiol. Behav. 77 (2002) 489-493
43. Haller J., Varga B., Ledent C., and Freund T.F. CB1 cannabinoid receptors mediate anxiolytic effects: Convergent genetic and pharmacological evidence with CB1-specific agents. Behav. Pharmacol. 15 (2004) 299-304
44. Haller J., Matyas F., Soproni K., Varga B., Barsy B., Nemeth B., Mikics E., Freund T.F., and Hajos N. Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission. Eur. J. Neurosci. 25 (2007) 2445-2456
45. Hampson R.E., and Deadwyler S.A. Cannabinoids, hippocampal function and memory. Life Sci. 65 (1999) 715-723
46. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., and Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J. Neurosci. 11 (1991) 563-583
47. Hill M.N., and Gorzalka B.B. Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test. Eur. Neuropsychopharmacol 15 (2005) 593-599
48. Hohmann A.G., Suplita R.L., Bolton N.M., Neely M.H., Fegley D., Mangieri R., Krey J.F., Walker J.M., Holmes P.V., Crystal J.D., Duranti A., Tontini A., et al. An endocannabinoid mechanism for stress-induced analgesia. Nature 435 (2005) 1108-1112
49. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., and Pertwee R.G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54 (2002) 161-202
50. Iwata J., LeDoux J.E., Meeley M.P., Arneric S., and Reis D.J. Intrinsic neurons in the amygdaloid field projected to by the medial geniculate body mediate emotional responses conditioned to acoustic stimuli. Brain Res. 383 (1986) 195-214
51. Jay T.M., and Witter M.P. Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of Phaseolus vulgaris-leucoagglutinin. J. Comp. Neurol. 313 (1991) 574-586
52. Kamprath K., and Wotjak C.T. Nonassociative learning processes determine expression and extinction of conditioned fear in mice. Learn. Mem. 11 (2004) 770-786
53. Kamprath K., Marsicano G., Tang J., Monory K., Bisogno T., Di Marzo V., Lutz B., and Wotjak C.T. Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes. J. Neurosci. 26 (2006) 6677-6686
54. Kathuria S., Gaetani S., Fegley D., Valino F., Duranti A., Tontini A., Mor M., Tarzia G., La Rana G., Calignano A., Giustino A., Tattoli M., et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med. 9 (2003) 76-81
55. Katona I., Rancz E.A., Acsady L., Ledent C., Mackie K., Hajos N., and Freund T.F. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J. Neurosci. 21 (2001) 9506-9518
56. Kesner R.P., Hunt M.E., Williams J.M., and Long J.M. Prefrontal cortex and working memory for spatial response, spatial location, and visual object information in the rat. Cereb. Cortex 6 (1996) 311-318
57. Kim J.J., and Fanselow M.S. Modality-specific retrograde amnesia of fear. Science 256 (1992) 675-677
58. Knowlton B.J., and Fanselow M.S. The hippocampus, consolidation and on-line memory. Curr. Opin. Neurobiol. 8 (1998) 293-296
59. Korte S.M. Corticosteroids in relation to fear, anxiety and psychopathology. Neurosci. Biobehav. Rev. 25 (2001) 117-142
60. Lafenetre P., Chaouloff F., and Marsicano G. The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction. Pharmacol. Res. 56 (2007) 367-381
61. Laviolette S.R., and Grace A.A. Cannabinoids potentiate emotional learning plasticity in neurons of the medial prefrontal cortex through basolateral amygdala inputs. J. Neurosci. 26 (2006) 6458-6468
62. Laviolette S.R., Lipski W.J., and Grace A.A. A subpopulation of neurons in the medial prefrontal cortex encodes emotional learning with burst and frequency codes through a dopamine D4 receptor-dependent basolateral amygdala input. J. Neurosci. 25 (2005) 6066-6075
63. LeDoux J.E. Brain mechanisms of emotion and emotional learning. Curr. Opin. Neurobiol. 2 (1992) 191-197
64. LeDoux J. Emotional networks and motor control: A fearful view. Prog. Brain Res. 107 (1996) 437-446
65. LeDoux J.E. Emotion circuits in the brain. Annu. Rev. Neurosci. 23 (2000) 155-184
66. LeDoux J.E., Iwata J., Cicchetti P., and Reis D.J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J. Neurosci. 8 (1988) 2517-2529
67. Lichtman A.H., Dimen K.R., and Martin B.R. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology (Berl.) 119 (1995) 282-290
68. Lisboa S.F., Resstel L.B., Aguiar D.C., and Guimaraes F.S. Activation of cannabinoid CB(1) receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test. Eur. J. Pharmacol. 593 (2008) 73-78
69. Malkani S., and Rosen J.B. Induction of NGFI-B mRNA following contextual fear conditioning and its blockade by diazepam. Brain Res. Mol. Brain Res. 80 (2000) 153-165
70. Maren S. Synaptic transmission and plasticity in the amygdala. An emerging physiology of fear conditioning circuits. Mol. Neurobiol. 13 (1996) 1-22
71. Maren S., and Fanselow M.S. Synaptic plasticity in the basolateral amygdala induced by hippocampal formation stimulation in vivo. J. Neurosci. 15 (1995) 7548-7564
72. Maren S., and Fanselow M.S. Electrolytic lesions of the fimbria/fornix, dorsal hippocampus, or entorhinal cortex produce anterograde deficits in contextual fear conditioning in rats. Neurobiol. Learn. Mem. 67 (1997) 142-149
73. Maren S., and Quirk G.J. Neuronal signalling of fear memory. Nat. Rev. Neurosci. 5 (2004) 844-852
74. Maren S., Aharonov G., and Fanselow M.S. Retrograde abolition of conditional fear after excitotoxic lesions in the basolateral amygdala of rats: Absence of a temporal gradient. Behav. Neurosci. 110 (1996) 718-726
75. Maren S., Aharonov G., Stote D.L., and Fanselow M.S. N-methyl-D-aspartate receptors in the basolateral amygdala are required for both acquisition and expression of conditional fear in rats. Behav. Neurosci. 110 (1996) 1365-1374
76. Maren S., Aharonov G., and Fanselow M.S. Neurotoxic lesions of the dorsal hippocampus and Pavlovian fear conditioning in rats. Behav. Brain Res. 88 (1997) 261-274
77. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., Hermann H., Tang J., Hofmann C., Zieglgansberger W., Di Marzo V., and Lutz B. The endogenous cannabinoid system controls extinction of aversive memories. Nature 418 (2002) 530-534
78. Matus-Amat P., Higgins E.A., Barrientos R.M., and Rudy J.W. The role of the dorsal hippocampus in the acquisition and retrieval of context memory representations. J. Neurosci. 24 (2004) 2431-2439
79. McKinney M.K., and Cravatt B.F. Structure and function of fatty acid amide hydrolase. Annu. Rev. Biochem. 74 (2005) 411-432
80. McSweeney F.K., and Swindell S. Common processes may contribute to extinction and habituation. J. Gen. Psychol. 129 (2002) 364-400
81. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R., Pertweee R.G., Griffine G., et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50 (1995) 83-90
82. Mikics E., Dombi T., Barsvari B., Varga B., Ledent C., Freund T.F., and Haller J. The effects of cannabinoids on contextual conditioned fear in CB1 knockout and CD1 mice. Behav. Pharmacol. 17 (2006) 223-230
83. Milad M.R., and Quirk G.J. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420 (2002) 70-74
84. Milad M.R., Vidal-Gonzalez I., and Quirk G.J. Electrical stimulation of medial prefrontal cortex reduces conditioned fear in a temporally specific manner. Behav. Neurosci. 118 (2004) 389-394
85. Moreira F.A., Aguiar D.C., and Guimaraes F.S. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray. Neuropharmacology 52 (2007) 958-965
86. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 (1993) 61-65
87. Myers K.M., and Davis M. Mechanisms of fear extinction. Mol. Psychiatry 12 (2007) 120-150
88. Navarro M., Hernandez E., Munoz R.M., del Arco I., Villanua M.A., Carrera M.R., and Rodriguez de Fonseca F. Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. Neuroreport 8 (1997) 491-496
89. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
90. Pacher P., Batkai S., and Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 58 (2006) 389-462
91. Pamplona F.A., and Takahashi R.N. WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors. Neurosci. Lett. 397 (2006) 88-92
92. Pamplona F.A., Prediger R.D., Pandolfo P., and Takahashi R.N. The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats. Psychopharmacology (Berlin) 188 (2006) 641-649
93. Pare D., and Smith Y. The intercalated cell masses project to the central and medial nuclei of the amygdala in cats. Neuroscience 57 (1993) 1077-1090
94. Pare D., and Smith Y. Intrinsic circuitry of the amygdaloid complex: Common principles of organization in rats and cats. Trends. Neurosci. 21 (1998) 240-241
95. Pare D., Quirk G.J., and Ledoux J.E. New vistas on amygdala networks in conditioned fear. J. Neurophysiol. 92 (2004) 1-9
96. Patel S., and Hillard C.J. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: Further evidence for an anxiolytic role for endogenous cannabinoid signaling. J. Pharmacol. Exp. Ther. 318 (2006) 304-311
97. Patel S., Roelke C.T., Rademacher D.J., Cullinan W.E., and Hillard C.J. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 145 (2004) 5431-5438
98. Patel S., Roelke C.T., Rademacher D.J., and Hillard C.J. Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling. Eur. J. Neurosci. 21 (2005) 1057-1069
99. Phillips R.G., and LeDoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 106 (1992) 274-285
100. Phillips R.G., and LeDoux J.E. Lesions of the dorsal hippocampal formation interfere with background but not foreground contextual fear conditioning. Learn. Mem. 1 (1994) 34-44
101. Pitkanen A., Savander V., and LeDoux J.E. Organization of intra-amygdaloid circuitries in the rat: An emerging framework for understanding functions of the amygdala. Trends Neurosci. 20 (1997) 517-523
102. Price M.R., Baillie G.L., Thomas A., Stevenson L.A., Easson M., Goodwin R., McLean A., McIntosh L., Goodwin G., Walker G., Westwood P., Marrs J., et al. Allosteric modulation of the cannabinoid CB1 receptor. Mol. Pharmacol. 68 (2005) 1484-1495
103. Quirk G.J., and Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33 (2008) 56-72
104. Quirk G.J., Likhtik E., Pelletier J.G., and Pare D. Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons. J. Neurosci. 23 (2003) 8800-8807
105. Ragozzino M.E., Adams S., and Kesner R.P. Differential involvement of the dorsal anterior cingulate and prelimbic-infralimbic areas of the rodent prefrontal cortex in spatial working memory. Behav. Neurosci. 112 (1998) 293-303
106. Resstel L.B., Joca S.R., Guimaraes F.G., and Correa F.M. Involvement of medial prefrontal cortex neurons in behavioral and cardiovascular responses to contextual fear conditioning. Neuroscience 143 (2006) 377-385
107. Resstel L.B., Joca S.R., Moreira F.A., Correa F.M., and Guimaraes F.S. Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats. Behav. Brain Res. 172 (2006) 294-298
108. Resstel L.B., Alves F.H., Reis D.G., Crestani C.C., Correa F.M., and Guimaraes F.S. Anxiolytic-like effects induced by acute reversible inactivation of the bed nucleus of stria terminalis. Neuroscience 154 (2008) 869-876
109. Resstel L.B., Correa F.M., and Guimaraes F.S. The expression of contextual fear conditioning involves activation of an NMDA receptor-nitric oxide pathway in the medial prefrontal cortex. Cereb. Cortex 18 (2008) 2027-2035
110. Resstel L.B., Joca S.R., Correa F.M., and Guimaraes F.S. Effects of reversible inactivation of the dorsal hippocampus on the behavioral and cardiovascular responses to an aversive conditioned context. Behav. Pharmacol. 19 (2008) 137-144
111. Resstel L.B., Lisboa S.F., Aguiar D.C., Correa F.M., and Guimaraes F.S. Activation of CB1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats. Psychopharmacology (Berlin) 198 (2008) 405-411
112. Rodriguez de Fonseca F., Carrera M.R., Navarro M., Koob G.F., and Weiss F. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276 (1997) 2050-2054
113. Rosen J.B. The neurobiology of conditioned and unconditioned fear: A neurobehavioral system analysis of the amygdala. Behav. Cogn. Neurosci. Rev. 3 (2004) 23-41
114. Royer S., Martina M., and Pare D. An inhibitory interface gates impulse traffic between the input and output stations of the amygdala. J. Neurosci. 19 (1999) 10575-10583
115. Schafe G.E., Bauer E.P., Rosis S., Farb C.R., Rodrigues S.M., and LeDoux J.E. Memory consolidation of Pavlovian fear conditioning requires nitric oxide signaling in the lateral amygdala. Eur. J. Neurosci. 22 (2005) 201-211
116. Sesack S.R., Deutch A.Y., Roth R.H., and Bunney B.S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: An anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J. Comp. Neurol. 290 (1989) 213-242
117. Sotres-Bayon F., Bush D.E., and LeDoux J.E. Emotional perseveration: An update on prefrontal-amygdala interactions in fear extinction. Learn. Mem. 11 (2004) 525-535
118. Sotres-Bayon F., Cain C.K., and LeDoux J.E. Brain mechanisms of fear extinction: Historical perspectives on the contribution of prefrontal cortex. Biol. Psychiatry 60 (2006) 329-336
119. Sullivan G.M., Apergis J., Bush D.E., Johnson L.R., Hou M., and Ledoux J.E. Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience 128 (2004) 7-14
120. Suzuki A., Josselyn S.A., Frankland P.W., Masushige S., Silva A.J., and Kida S. Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J. Neurosci. 24 (2004) 4787-4795
121. Takagishi M., and Chiba T. Efferent projections of the infralimbic (area 25) region of the medial prefrontal cortex in the rat: An anterograde tracer PHA-L study. Brain Res. 566 (1991) 26-39
122. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., and Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83 (1998) 393-411
123. Uriguen L., Perez-Rial S., Ledent C., Palomo T., and Manzanares J. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology 46 (2004) 966-973
124. Varvel S.A., and Lichtman A.H. Evaluation of CB1 receptor knockout mice in the Morris water maze. J. Pharmacol. Exp. Ther. 301 (2002) 915-924
125. Varvel S.A., Anum E.A., and Lichtman A.H. Disruption of CB(1) receptor signaling impairs extinction of spatial memory in mice. Psychopharmacology (Berlin) 179 (2005) 863-872
126. Vianna D.M., Allen C., and Carrive P. Cardiovascular and behavioral responses to conditioned fear after medullary raphe neuronal blockade. Neuroscience 153 (2008) 1344-1353
127. Viveros M.P., Marco E.M., and File S.E. Endocannabinoid system and stress and anxiety responses. Pharmacol. Biochem. Behav. 81 (2005) 331-342
128. Weidenfeld J., Feldman S., and Mechoulam R. Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat. Neuroendocrinology 59 (1994) 110-112
129. Wilson R.I., and Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410 (2001) 588-592